Mustang Bio, INC Schedule 13D activist filings

Fortress Biotech, Inc. has increased its beneficial ownership in Mustang Bio, Inc. to 8.0% following an annual equity grant and maintains a voting majority through preferred stock.

Fortress Biotech, Inc. reported a decrease in its beneficial ownership of Mustang Bio, Inc. common stock to 4.0%, falling below the 5% threshold due to recent equity grants.

Fortress Biotech, Inc. has filed an Amendment No. 5 to its Schedule 13D, updating its beneficial ownership in Mustang Bio, Inc. to 7.9% and reaffirming its control through Class A preferred stock.

Fortress Biotech, Inc. has increased its beneficial ownership in Mustang Bio, Inc. to 12.4% of common stock, primarily through equity grants and preferred stock, solidifying its majority voting control.